Company / CapEx per Share
Amneal Pharmaceuticals, Inc. CapEx per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.40
FY2025
5-year range
$0.31 / $0.40
FY2021-FY2025
Trend
+15.6%
vs FY2024
Sector context
#33 of 192
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s capex per share of $0.40 is higher than 83% of companies in the Health Care sector (FY2025). CapEx per Share has increased for 3 consecutive years, from $0.31 in FY2022 to $0.40 in FY2025.
Based on SEC 10-K filings.
0.40 in FY2025 with a 5-year CAGR of -9.4%. Top quartile in the Health Care sector.
Improved from $0.31 to $0.40 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +8.5%
- 5-Year CAGR
- -9.4%
- 10-Year CAGR
- -
Sector benchmark
-88.8% below sector average
Key checks
Key Insights
- Amneal Pharmaceuticals, Inc.'s capex per share has grown for 3 consecutive years.
- In FY2025, capex per share increased 15.6% year-over-year.
- Ranks #33 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.40 | +15.6% |
| FY2024 | $0.34 | +9.4% |
| FY2023 | $0.31 | +0.9% |
| FY2022 | $0.31 | -12.7% |
| FY2021 | $0.36 | -45.3% |
| FY2020 | $0.65 | -12.3% |
| FY2019 | $0.74 | -22.8% |
| FY2018 | $0.96 | -100.0% |
| FY2017 | $94771.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026